Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-02-26
Summary
Research study to look for bio markers in epilepsy patients on ketogenic diet
Conditions
Interventions
- OTHER
-
Diet
Ketogenic diet
Sponsors & Collaborators
- collaborator OTHER
-
Senda Biosciences
lead INDUSTRY
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-15
- Primary Completion
- 2021-02-23
- Completion
- 2021-02-23
Countries
- United States
Study Locations
More Related Trials
-
Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
NCT04542629 ·Status: UNKNOWN ·Phase: PHASE4
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2
-
BOTOX Effects on Seizure Severity and Susceptibility
NCT05605756 ·Status: TERMINATED ·Phase: PHASE4
-
The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet
NCT05898438 ·Status: UNKNOWN
-
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
NCT03336242 ·Status: TERMINATED ·Phase: PHASE2
-
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
NCT02239276 ·Status: NO_LONGER_AVAILABLE
-
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
NCT01899898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients
NCT03403907 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)
NCT03676049 ·Status: AVAILABLE
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
Epidiolex and Drug Resistant Epilepsy in Children
NCT02397863 ·Status: AVAILABLE
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabis Extract in Refractory Epilepsy Study
NCT03808935 ·Status: TERMINATED ·Phase: PHASE3
-
Adjunctive Everolimus Treatment of Refractory Epilepsy
NCT05613166 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Cannabidiol for Drug-Resistant Epilepsies
NCT03014440 ·Status: NO_LONGER_AVAILABLE
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
Study in Pediatric Subjects With Epilepsy
NCT01494584 ·Status: TERMINATED ·Phase: PHASE2
-
Cardiovascular Risk Reduction in Epilepsy
NCT05704439 ·Status: WITHDRAWN ·Phase: NA
-
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT05772429 ·Status: ACTIVE_NOT_RECRUITING
-
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268 ·Status: UNKNOWN
-
Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.
NCT05346666 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA